Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1260825.RAXYO-Evk4g9CO1EposGC4SXTUlVfgfWwI-3Cb6z0LHxw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1260825.RAXYO-Evk4g9CO1EposGC4SXTUlVfgfWwI-3Cb6z0LHxw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1260825.RAXYO-Evk4g9CO1EposGC4SXTUlVfgfWwI-3Cb6z0LHxw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1260825.RAXYO-Evk4g9CO1EposGC4SXTUlVfgfWwI-3Cb6z0LHxw130_provenance.
- NP1260825.RAXYO-Evk4g9CO1EposGC4SXTUlVfgfWwI-3Cb6z0LHxw130_assertion description "[MIR-93 mRNA expression was also negatively associated with differentiation (well vs. poor and moderate) and International Federation of Gynecology and Obstetrics staging (FIGO stage I/II vs. stage III/IV) in ovarian carcinoma (p?<?0.05), besides, miR-93 was higher expressed in mucinous adenocarcinoma than the other types (p?<?0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260825.RAXYO-Evk4g9CO1EposGC4SXTUlVfgfWwI-3Cb6z0LHxw130_provenance.
- NP1260825.RAXYO-Evk4g9CO1EposGC4SXTUlVfgfWwI-3Cb6z0LHxw130_assertion evidence source_evidence_literature NP1260825.RAXYO-Evk4g9CO1EposGC4SXTUlVfgfWwI-3Cb6z0LHxw130_provenance.
- NP1260825.RAXYO-Evk4g9CO1EposGC4SXTUlVfgfWwI-3Cb6z0LHxw130_assertion SIO_000772 25649143 NP1260825.RAXYO-Evk4g9CO1EposGC4SXTUlVfgfWwI-3Cb6z0LHxw130_provenance.
- NP1260825.RAXYO-Evk4g9CO1EposGC4SXTUlVfgfWwI-3Cb6z0LHxw130_assertion wasDerivedFrom befree-2016 NP1260825.RAXYO-Evk4g9CO1EposGC4SXTUlVfgfWwI-3Cb6z0LHxw130_provenance.
- NP1260825.RAXYO-Evk4g9CO1EposGC4SXTUlVfgfWwI-3Cb6z0LHxw130_assertion wasGeneratedBy ECO_0000203 NP1260825.RAXYO-Evk4g9CO1EposGC4SXTUlVfgfWwI-3Cb6z0LHxw130_provenance.
- befree-2016 importedOn "2016-02-19" NP1260825.RAXYO-Evk4g9CO1EposGC4SXTUlVfgfWwI-3Cb6z0LHxw130_provenance.